According to the latest data from the Hong Kong Stock Exchange, on May 19, Huatai-PineBridge Fund sold 160,000 shares of REMEGEN at an average price of HK$84.8306 per share, with a total transaction value of approximately HK$13.5729 million. Following this reduction, the fund's holding in REMEGEN stands at 10.3745 million shares, representing a 4.97% stake.